TILT (TILT) Q3 2024 earnings summary

Executive summary

• Management is pursuing strategic alternatives for plant-touching assets, including divestitures or partnerships, to focus on the Jupiter Research segment and inhalation technology, aiming to address balance sheet challenges and unlock value in the core business.

• Leadership changes and operational restructuring have been implemented, including new COO and commercial head for Jupiter, board changes, and new hires with expertise in strategic growth and commercialization.

• The company is advancing an asset-light model for Jupiter, emphasizing just-in-time production and direct invoicing by suppliers to improve working capital.

• Market conditions in cannabis remain challenging, with pricing pressure, regulatory hurdles, and market saturation impacting operations in Massachusetts, Pennsylvania, and Ohio.

• Launched Edie Parker Flower in Pennsylvania and made board and executive leadership changes.

Financial highlights

• Q3 2024 revenue was $27 million, up sequentially from Q2 but down from $44.6 million year-over-year, mainly due to lower Jupiter hardware sales and shipping delays.

• Jupiter revenue increased sequentially to $16.8 million from $15.7 million in Q2, but declined from $32.8 million year-over-year.

• Gross margin was 14% in Q3, down from 16% in Q2 and 18% year-over-year; adjusted gross margin was 15%.

• Net loss was $12.6 million, widened from $8.7 million year-over-year; adjusted EBITDA was negative $1.6 million.

• Cash flow from operations was $2 million, with $3.9 million in cash and equivalents at quarter-end.

Outlook and guidance

• Management expects that focusing on Jupiter and divesting plant-touching assets will reduce operational expenses, improve the balance sheet, and optimize the business portfolio.

• Anticipates continued growth in all-in-one vaporization devices, new product launches, and European market opportunities.

• Regulatory changes in Ohio and product innovation are expected to support future growth.

• No set deadline for the strategic review; future actions may include joint ventures, partnerships, or asset sales.

• Management expects the asset-light Jupiter model to improve working capital and product alignment.